Discovery Sheds Light on Viral Compartment Formation in HIV/AIDs

The human immunodeficiency virus (HIV) attacks the immune system and can lead to autoimmune deficiency syndrome (AIDS) if not treated. During infection, dendritic cells capture and transmit the HIV virus and initiate an immune response. Siglec-1, a membrane protein that distinguishes foreign pathogens, plays a crucial role in the early stages of HIV infection by helping dendritic cells recognize and bind to the virus. Recently, scientists identified Siglec-1 as the main receptor on activated dendritic cells that binds to specific molecules of HIV-1 particles, but the exact mechanisms of this process are not well known. 

To understand the role of Siglec-1 in the immune response to HIV, researchers analyzed the spatial organization of Siglec-1 on dendritic cell membranes, uncovering more about its significant role in the early stages of infection.

Using techniques like super-resolution microscopy and single particle tracking, the team found that activating dendritic cells leads to forming Siglec-1 nanoclusters, which are instrumental in enhancing the capture of HIV-like particles. The researchers also discovered that the organization and mobility of these nanoclusters are regulated by actin polymerization, a key cellular process that plays a role in numerous biological functions.

Most notably, the binding of the virus via the nanoclustering of Siglec-1 triggers a massive and global transformation of the dendritic cells’ actin cytoskeleton, leading to the formation of a single sack-like compartment that accumulates the viruses. This viral compartment has been implicated in viral spreading and infecting T-cells, ultimately leading to AIDS. The team’s findings shed light on the mechanism behind the formation of this compartment, which is crucial to developing effective therapies for people living with HIV/AIDS.

Super-resolution microscopy and single-particle tracking methods allowed the team to better understand the mechanisms regulating the interaction between viruses and cells, especially receptor distribution and function.

With these techniques, researchers can directly visualize how viruses are captured by cells and follow their fate until the final infection of immune cells. These findings, published in eLife, aim to help researchers develop new tools to combat HIV and improve the lives of those affected by it.